Corporate Profile for Faulding Inc., dated July 26th.--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and information services See Information Systems. . These include Dow Jones Dow Jones the best known of several U.S. indexes of movements in price on Wall Street. [Am. Hist.: Payton, 202] See : Finance News/Retrieval, Bloomberg Financial Markets, Reuter Company Newsyear, Reuter Business Briefing, DataTimes, Nexis, Dialog, NewsNet, America OnLine See AOL. , CompuServe, Delphi, Individual's HeadsUp and First!, Desktop Data's NewsEdge, UMI UMI University Microfilms International UMI United States Minor Outlying Islands (ISO Country code) UMI University of Miami UMI Universal Management Infrastructure (IBM) Data Courier, NewsBank, Information Access Company, Prodigy, Comtex, and many others. -0- Published Date: July 26, 1996 Company Name: Faulding Inc.
Address: 200 Elmora Avenue
Elizabeth, NJ 07207
Main Telephone Number: 908/627-9100 Chief Executive Officer: Richard F. Moldin Investor Relations Contact: Lee Craker Business number: 908/527-9100 x202 Home number: 203/762-3995 Public Relations Contact: Lee Craker Business number: 908/527-9100 x202 Home number: 203/762-3995 Trading Symbol: FAUL (on NASDAQ) Industry: Generic Pharmaceuticals Company description: Faulding Inc. (formerly Purepac Inc.) is a leading oral generic pharmaceutical sales and manufacturing operation based in Elizabeth, N.J. The last year has seen this business start to undergo a significant transformation, signaled by the following: - The acquisition of a generic injectables and device business from its major stockholder F.H. Faulding & Co., Ltd. - The name change for its publicly traded company publicly traded company A company whose shares of common stock are held by the public and are available for purchase by investors. The shares of publicly traded firms are bought and sold on the organized exchanges or in the over-the-counter market. from Purepac Inc. to Faulding Inc. - And, perhaps more significantly, a major upgrade of its senior management staff including the appointment of Richard F. Moldin as CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. in July of 1995. Faulding Inc.'s earnings over the last year have been impacted by the lack of new FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ANDA ANDA abbr. abbreviated new drug application approvals. The recent approvals of diclofenac, diflunisal, and indapamide have the potential to help improve its earnings while it digests the new acquisitions and completes its management reorganization. Via the above acquisitions, the business is now expanding into the injectable and device arenas, including the incorporation of the injectable anti-cancer product range being licensed in from F.H. Faulding & Co., Ltd. Sales of those products commenced in January 1996. These product ranges will complement the present Purepac oral generic range. CONTACT: Faulding Inc. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion